dQ&A launched the beta of our next-gen AI Insights Platform—a breakthrough natural language solution providing instant, data-driven answers for the diabetes market.
dQ&A launches a new tracking study of Italians with type 1 and type 2 diabetes, capturing real-world insights on care, technology use, and daily challenges.
dQ&A was honored to participate in the 2019 ADA Scientific Sessions with five posters and an abstract highlighting our work.
Our study reveals that perceptions of hypoglycemia profoundly shape life with diabetes, exposing its broad mental, emotional, and physical toll.
Our research reveals how diabetes-friendly grocery stores really are, uncovering key barriers and ways to improve the shopping experience.
It’s important to be sure you have high-quality answers before making important clinical or commercial decisions.
A 3,000-person dQ&A survey shows 9% of those with T1D and 17% of those with T2D on insulin reported that they have self-rationed insulin because of cost.
Our research found that diabetes keeps many awake at night due to symptoms, complications, and comorbidities of diabetes.
We looked back at the 10-year trends in diabetes drug and device penetration in the dQ&A Community—here's what we found.
